Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Teva announces generic Reyataz capsules

Teva has introduced its generic of Reyataz (atazanavir) capsules within the United States, the company announced. The drug is indicated to be used in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients six years old and older who weigh at least 15 kg.

Atazanavir structure.svg

“The exclusive launch of our generic version of Reyataz marks our fifth generic product offering for the treatment of HIV-1 infection,” Brendan O’Grady, executive vice president, North America Commercial at Teva said. “Antiviral medications continue to be a focus for Teva Generics, and this is an important addition to our portfolio.”

Reyataz had annual sales of approximately $402 million in the U.S. as of October 2017, according to IQVIA data.


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies